LPTX
Leap Therapeutics, Inc.
NASDAQ · Healthcare · Biotechnology · US
$0.77
−3.15%Margins
Gross margin
-9631.6%
EBITDA margin
—
EBIT margin
—
Net margin
2307.2%
FCF margin
—
3.1%
Return on equity
3.0%
Return on assets
-26.7%
Return on invested capital
0.00x
Asset turnover
-$88.7M
Cash from operations
$0.34
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Dec 1, 2025